All News
Filter News
Found 808,991 articles
-
Prominent ophthalmologist will guide Turn Bio's search for therapies to cure eye diseases
8/22/2022
Turn Biotechnologies announced that Albert Wu, MD, PhD, will oversee its development of ophthalmic therapeutic products as an advisor to the company.
-
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine
8/22/2022
Pfizer Inc. and BioNTech SE announced they have completed a submission to the U.S. Food and Drug Administration requesting Emergency Use Authorization of a booster dose of an Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for individuals 12 years of age and older.
-
American Marketing Association Recognizes March of Dimes Chief Marketing Officer, Cindy Rahman, as the 2022 National Nonprofit Marketer of the Year
8/22/2022
March of Dimes is excited to announce its recognition in more than a dozen marketing and communication industry awards in 2022 recognizing outstanding leadership in public relations, as well as work in creative video production, integrated campaign development and more.
-
Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA
8/22/2022
Ascletis Pharma Inc. announces that the China National Medical Products Administration has approved the Investigational New Drug application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase for COVID-19.
-
Porton Advanced Solutions completes a Series B financing round to expand its end-to-end Gene and Cell Therapy CDMO Platforms
8/22/2022
On August 19, 2022, Porton Advanced Solutions announced the completion of its Series B financing round with over US$80Million.
-
Thermo Fisher Scientific’s Largest Single-Use Technology Manufacturing Site Opens in Greater Nashville
8/22/2022
Thermo Fisher Scientific Inc., the world leader in serving science, opened its largest single-use technology manufacturing site in Greater Nashville.
-
American Academy of HIV Medicine Launches Long-acting Agents Resource Center
8/22/2022
This week, the American Academy of HIV Medicine launched a new online resource, www.hivlaa.org, to expand the knowledge base for long-acting antiretroviral agents used for the treatment and prevention of HIV.
-
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Aug 22, 2022
8/22/2022
Albireo Pharma, Inc., a rare liver disease company developing novel bile acid modulators, announced the grant of inducement restricted stock units to acquire 17,300 shares of Albireo’s common stock.
-
InnoCare Releases 2022 Mid-Year Results and Business Highlights
8/22/2022
Aug. 22, 2022 00:30 UTC InnoCare Pharma, a leading biopharmaceutical company focusing on cancer and autoimmune diseases, announced 2022 mid-year results which ended on June 30, 2022.
-
Atrion Corporation Increases Quarterly Cash Dividend by 10%
8/22/2022
Atrion Corporation (Nasdaq ATRI) today announced an increase in its quarterly cash dividend from $1.95 per share to $2.15 per share.
-
Biocept Announces Receipt of Deficiency Notice from Nasdaq Regarding Requirement to Timely Quarterly Report on Form 10-Q
8/22/2022
Biocept, Inc . (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that it received a notice (the “Notice”) on August 17, 2022 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising Biocept that it was not in compliance with Nasdaq’s continued listing requirements under the Nasdaq Listing Rule 5250(c)(1).
-
Pi-Cardia Successfully Performs Mitral Valve Splitting With ShortCut(TM)
8/22/2022
Pi-Cardia Ltd., a global leader in the development of non-implant, catheter-based solutions for treating heart valves, announced a successful First-In-Human treatment of the mitral valve with the ShortCut™ Mitral device in Europe.
-
BD Announces Pricing of the Tender Offers
8/22/2022
Becton, Dickinson and Company (NYSE: BDX) (the " Company " or " BD ") today announced the consideration payable in connection with its previously announced Tender Offers (as defined below) to purchase for cash up to $500,000,000 aggregate principal amount.
-
Source BioScience launches Sanger Sequencing Service in San Diego, CA to support life science researchers with market-leading genomic services
8/22/2022
A leading provider of Genomic services in the UK and Ireland, Source BioScience ("Source"), a part of SourceBio International plc, is now bringing decades of expertise and customer satisfaction in Genomic services to the USA.
-
Arcutis Announces Arcutis Cares™ Patient Assistance Program (PAP) For Financially Qualified Uninsured and Underinsured Patients
8/22/2022
Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, announced that Arcutis Cares, the first ever patient assistance program for a topical psoriasis product, is open for enrollment.
-
City of Hope and FivePoint Invite Orange County, Calif. Residents to Rise Above Cancer as Great Park Balloon Soars with Messages of Hope
8/22/2022
City of Hope, one of the largest cancer research and treatment organizations in the United States, is sending the iconic Great Park Balloon in Irvine, California, into the sky with a message of hope for ending the disease that affects 1 in 3 Americans in their lifetime.
-
RELIEF THERAPEUTICS HOLDING SA AND NRX PHARMACEUTICALS, INC. ANNOUNCE TENTATIVE SETTLEMENT OF PENDING LITIGATION
8/22/2022
RELIEF THERAPEUTICS and NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) (" NRx "), today announced that they have agreed to a tentative settlement of their pending litigation.
-
Elevar Therapeutics Names Wade Smith Chief Financial OfficerTwo-decade industry veteran joined Elevar as VP of finance in January
8/22/2022
Elevar Therapeutics, Inc. today announced the appointment of Wade Smith as chief financial officer.
-
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery Signs Definitive Agreement to Acquire Standard Bariatrics
8/22/2022
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has entered into a definitive agreement to acquire Standard Bariatrics, Inc. which has commercialized an innovative powered stapling technology for bariatric surgery.
-
Veru Granted Expedited Provisional Registration Regulatory Pathway for Sabizabulin Treatment in Hospitalized COVID-19 Patients by Australia’s Therapeutic Goods Administration
8/22/2022
Veru Inc. today announced that Australia’s Therapeutic Goods Administration (TGA) has determined that sabizabulin treatment in hospitalized COVID-19 patients at high risk for Acute Respiratory Distress Syndrome (ARDS) qualifies for an expedited, provisional registration regulatory pathway.